L-Asparagine

L-Asparagine at a Glance

L-Asparagine was the first amino acid ever isolated — from asparagus juice in 1806, which is where the name comes from. It is the amide of aspartic acid, and the body makes it on demand from aspartate and glutamine, so it never needs to come from the diet.

That last fact is most of the story. There is no deficiency state, no reference intake, and essentially no evidence base for taking asparagine as a standalone supplement.

What makes asparagine scientifically interesting is that the compelling findings all point the other way. The best-replicated results in this literature are about depleting asparagine, not supplying it: the leukaemia drug asparaginase works by stripping it out of the blood, and dietary restriction reduces metastasis in preclinical cancer models. And the one fact about dietary asparagine that matters to the general public is a food-chemistry problem rather than a supplement benefit — free asparagine is what turns into acrylamide when starchy foods are fried or baked.

What It’s Used For

Very little, honestly. It is rarely sold as a single-ingredient product, appearing mostly inside broader amino-acid mixtures or intravenous nutrition formulas.

Cognitive / nervous-system support — the only claim with even a mechanistic peg, and it scores at the floor: cell-culture work and tissue presence, with no human trial of any kind.

Treat any product marketing standalone L-asparagine for performance, cognition or general wellness as resting on mechanism and analogy rather than human outcome data. The single controlled human supplementation trial — 7 g of asparagine with 7 g of aspartate before high-intensity exercise — found nothing: no effect on performance, lactate or glycogen sparing.

How It Works

Asparagine’s defining feature is its amide side chain. Transamination interconverts it freely with aspartate, which ties it into general nitrogen and ammonia handling. And because that amide nitrogen is a chemical handle, asparagine residues in proteins are the attachment sites for N-linked glycans — a foundational step in building enzymes, receptors and secreted proteins.

The body synthesises it via asparagine synthetase (ASNS), an ATP-dependent, stress-inducible enzyme that draws nitrogen from glutamine. That enzyme is the pivot for the interesting biology: cells that express little ASNS — including many acute lymphoblastic leukaemia cells — cannot make their own asparagine and must import it, which is exactly the vulnerability asparaginase therapy exploits.

More recently, asparagine has turned out to couple mitochondrial respiration to ATF4 and mTORC1 signalling, enabling the nucleotide synthesis that proliferating cells need. That is a growth signal, which is why the modern literature reads as a case for restricting asparagine rather than adding it.

The full research picture is in Pharmacology & Research below.

Pharmacology & Research

L-Asparagine is a nonessential α-amino acid — the amide of aspartic acid — that the body synthesises on demand from aspartate and glutamine via the enzyme asparagine synthetase (ASNS). Because endogenous supply is normally adequate and the amino acid is abundant in dietary protein, there is no recognised deficiency state and almost no evidence base for taking it as a standalone supplement. The scientifically compelling story is, in fact, inverted: the strongest, most replicated findings concern depleting or restricting asparagine — the leukaemia drug asparaginase and dietary-restriction models in cancer — rather than supplementing it ^{1,5Reference 1Knott SRV et al. · 2018AnimalAsparagine bioavailability governs metastasis in a model of breast cancer — in vivo / RNAi studyView study →Reference 5Chen SH · 2015ReviewAsparaginase therapy in pediatric acute lymphoblastic leukemia: a focus on the mode of drug resistance — reviewView study →}.

Where asparagine does matter for the general public it is largely a food-chemistry issue (it is the precursor of acrylamide in cooked starchy foods) rather than a supplement benefit ^{9Reference 9Yaylayan VA · 2005ReviewAcrylamide formation in food: a mechanistic perspective — mechanistic reviewView study →}.

Treat any product marketing standalone L-asparagine for performance, cognition, or general wellness as resting on mechanism and analogy, not on human outcome data.

Best-supported:Nothing rises to the level of a proven standalone-supplement benefit in healthy, well-nourished people. As a dietary amino acid it contributes to protein synthesis, nitrogen/ammonia handling, and N-linked glycosylation, but a replete body already makes what it needs ^{3,6Reference 3Jiang J et al. · 2021ReviewAsparagine: a metabolite to be targeted in cancers — reviewView study →Reference 6Lomelino CL et al. · 2017ReviewAsparagine synthetase: function, structure, and role in disease — reviewView study →}.

Emerging / cautiously endorsed:The best-replicated asparagine biology is about restriction, not intake — limiting asparagine (by asparaginase, ASNS knockdown, or dietary restriction) reduces metastasis in a breast-cancer model and impairs tumour growth and germinal-center B-cell responses in mice ^{1,2,8Reference 1Knott SRV et al. · 2018AnimalAsparagine bioavailability governs metastasis in a model of breast cancer — in vivo / RNAi studyView study →Reference 2Krall AS et al. · 2021AnimalAsparagine couples mitochondrial respiration to ATF4 activity and tumor growth — in vivo / mechanisticView study →Reference 8Yazicioglu YF et al. · 2024AnimalAsparagine availability controls germinal center B cell homeostasis — in vivo / mechanisticView study →}. This is preclinical and points away from supplementing.

Popular but thin / overhyped:“Energy,” anti-fatigue, and cognitive/nervous-system support claims rest on cell-culture and rodent work or on asparagine’s textbook biochemical roles, not on human supplement trials ^{12Reference 12Brewer GJ et al. · 1993In vitroOptimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination — in vitroView study →}.

The honest miss / caveat:A double-blind human trial of acute aspartate + asparagine (7 g each) before high-intensity exercise found no effect on performance, lactate, or glycogen sparing — a well-evidenced null ^{11Reference 11Parisi A et al. · 2007RCTDo aspartate and asparagine acute supplementation influence the onset of fatigue in intense exercise? — randomised double-blind pilotView study →}. And a theoretical caution: because asparagine availability promotes metastatic behaviour in preclinical cancer models, deliberately loading it is, if anything, a reason for caution rather than benefit ^{1Reference 1Knott SRV et al. · 2018AnimalAsparagine bioavailability governs metastasis in a model of breast cancer — in vivo / RNAi studyView study →}.

Evidence by IndicationStrength of support · Beta

Support is an experimental score I’m building — a composite weighted by study type (human > animal > in vitro > review) and study volume. It’s a beta: a fast way to rank strength of evidence at a glance, not a validated metric. For L-asparagine the table is deliberately sparse, because there is very little credible evidence for any standalone-supplement benefit; the honest reading is in the takeaways above.

Mechanisms

Target / pathway	Effect	Relevant to
Asparagine synthetase (ASNS)	Synthesises Asn from aspartate + glutamine (ATP-dependent); stress-inducible	Endogenous supply; cancer metabolism and asparaginase resistance
N-linked glycosylation	Asn residues are the attachment sites for N-linked glycans	Protein foldingstabilitytrafficking
ATF4 / mTORC1 signalling	Asn couples mitochondrial respiration to ATF4 and mTORC1, enabling nucleotide synthesis	Cell proliferationtumour growth
Nitrogen / ammonia handling	Transamination interconverts Asn ⇄ aspartate; the ω-amidase pathway feeds glutamine/asparagine nitrogen metabolism	Nitrogen transporthyperammonaemic states
EMT-associated proteins	Asn availability influences invasive / epithelial-to-mesenchymal potential	Metastatic behaviour (preclinical)

Pharmacokinetics

L-Asparagine is a nonessential amino acid, so plasma levels are maintained largely by endogenous synthesis (ASNS) plus dietary protein rather than by any single oral dose. Dietary asparagine — protein-bound or free — is absorbed in the small intestine through the same neutral-amino-acid transport systems used by other amino acids, then enters the general amino-acid pool where it is freely interconverted with aspartate by transamination ^{7Reference 7Cooper AJL et al. · 2016ReviewCooper AJL, Shurubor YI, Dorai T, et al. (2016). ω-Amidase: an underappreciated but important enzyme in L-glutamine and L-asparagine metabolism — review. Amino Acids. https://pubmed.ncbi.nlm.nih.gov/26259930/View study →}. There is no established oral bioavailability figure or supplement-specific half-life for isolated L-asparagine, because it has not been formally studied as a standalone supplement; it is not stored in a dedicated pool, and excess amino-acid nitrogen is disposed of via the urea cycle. The decision-relevant point is that, for a molecule the body already makes to demand, oral supplementation has no defined pharmacokinetic advantage over ordinary dietary protein.

Clinical trials

Registered clinical-trial activity for L-asparagine as a supplement is essentially nil. The large trial literature filed under “asparagine” concerns the depleting drug asparaginase in acute lymphoblastic leukaemia — the opposite of supplementation — and, more recently, dietary-asparagine-restriction studies as adjuncts in oncology ^{1,5,13Reference 1Knott SRV et al. · 2018AnimalAsparagine bioavailability governs metastasis in a model of breast cancer — in vivo / RNAi studyView study →Reference 5Chen SH · 2015ReviewAsparaginase therapy in pediatric acute lymphoblastic leukemia: a focus on the mode of drug resistance — reviewView study →Reference 13Richards NGJ · 2006ReviewAsparagine synthetase chemotherapy — reviewView study →}. Off-patent and with no supplement industry behind it, standalone L-asparagine has attracted no meaningful human efficacy trials.

Completed	Planned	Terminated	Preclinical
0(supplement efficacy)	0	0	Dozens(mostly cancer/leukaemia metabolism)

Last checked: August 2026.

Dietary Sources

Asparagine is one of the most broadly distributed amino acids in the food supply, occurring in essentially all dietary protein and also as a free amino acid in many plants — asparagus, from which it was first isolated in 1806, takes its name here. Because it is nonessential and ubiquitous, there is no NIH Office of Dietary Supplements fact sheet and no reference intake for asparagine specifically. A normal mixed diet supplies far more than a supplement capsule would, and the body tops up the rest by synthesis.

Free (unbound) asparagine is worth distinguishing from protein-bound asparagine, because free asparagine in starchy plant foods is the precursor that forms acrylamide when those foods are fried, roasted or baked at high temperature ^{9,10Reference 9Yaylayan VA · 2005ReviewAcrylamide formation in food: a mechanistic perspective — mechanistic reviewView study →Reference 10Oliver SL et al. · 2024ReviewReducing acrylamide formation potential by targeting free asparagine accumulation in seeds — review/perspectiveView study →}.

Food group	Relative asparagine content	Notes
Asparagus, legumes (soy, beans), nuts/seeds	High (much as free asparagine)	Namesake source; free Asn relevant to cooking chemistry
Beef, poultry, eggs, dairy, fish/seafood	High (protein-bound)	Animal protein is Asn-rich as part of complete protein
Potatoes, cereal grains (wheat, rye)	Moderate–high free asparagine	Main dietary route to acrylamide when browned or fried ^{9,10Reference 9Yaylayan VA · 2005ReviewAcrylamide formation in food: a mechanistic perspective — mechanistic reviewView study →Reference 10Oliver SL et al. · 2024ReviewReducing acrylamide formation potential by targeting free asparagine accumulation in seeds — review/perspectiveView study →}
Whole grains, whole vegetables	Moderate	Refining grains lowers free amino-acid content

Values are qualitative: no authoritative per-food asparagine database comparable to the ODS nutrient sheets exists, because asparagine is not a regulated essential nutrient.

Intake & Dosage

These are doses studied in research, not a personal recommendation.

There is no RDA, AI, or Tolerable Upper Intake Level for L-asparagine. As a nonessential amino acid the body synthesises it, and the reference-value bodies (IOM/DRI, EFSA) have set no intakes for it. Typical intake is simply whatever is contained in ordinary dietary protein, which is ample.

No standalone supplemental dose has been established or validated for any health outcome. The only controlled human dosing on record is a 7 g acute dose, combined with 7 g of aspartate, used in an exercise pilot — which showed no benefit ^{11Reference 11Parisi A et al. · 2007RCTDo aspartate and asparagine acute supplementation influence the onset of fatigue in intense exercise? — randomised double-blind pilotView study →}.

Safety

As a normal component of food and of the body’s own metabolism, L-asparagine is regarded as safe at dietary levels. The two cautions worth stating are both about deliberately loading it.

Safety at a Glance

Low / no toxicityDrug interactions

Safe as a normal dietary component. It is in essentially all dietary protein, and the body synthesises its own.
Do not supplement while on asparaginase therapy. The drug works by depleting circulating asparagine; supplementing directly opposes its mechanism ^{5,13Reference 5Chen SH · 2015ReviewAsparaginase therapy in pediatric acute lymphoblastic leukemia: a focus on the mode of drug resistance — reviewView study →Reference 13Richards NGJ · 2006ReviewAsparagine synthetase chemotherapy — reviewView study →}.
Theoretical caution in cancer. Higher asparagine availability promotes metastatic behaviour and tumour growth in preclinical models, and dietary restriction is being studied as an adjunct ^{1,2Reference 1Knott SRV et al. · 2018AnimalAsparagine bioavailability governs metastasis in a model of breast cancer — in vivo / RNAi studyView study →Reference 2Krall AS et al. · 2021AnimalAsparagine couples mitochondrial respiration to ATF4 activity and tumor growth — in vivo / mechanisticView study →}.
Concentrated doses are uncharacterised. It is rarely sold standalone, so specific adverse-effect thresholds are not defined — absence of reports is not evidence of safety.
No upper limit is set. No UL exists; this does not imply unlimited intake is safe.

Full Safety & Interactions Detail

Because L-asparagine is seldom taken as an isolated supplement, the safety of concentrated standalone doses has not been formally characterised, and specific adverse-effect thresholds are not defined.

The asparaginase interaction is the material one. Asparaginase, used in acute lymphoblastic leukaemia and some lymphomas, works by depleting circulating asparagine so that leukaemia cells lacking asparagine synthetase starve ^{5,13Reference 5Chen SH · 2015ReviewAsparaginase therapy in pediatric acute lymphoblastic leukemia: a focus on the mode of drug resistance — reviewView study →Reference 13Richards NGJ · 2006ReviewAsparagine synthetase chemotherapy — reviewView study →}. Supplemental L-asparagine would directly oppose that mechanism. Patients on asparaginase should not take it. No other well-characterised drug interaction is established.
The oncologic caution is theoretical but consistent. In preclinical models, higher asparagine availability promotes metastatic behaviour and tumour growth ^{1,2Reference 1Knott SRV et al. · 2018AnimalAsparagine bioavailability governs metastasis in a model of breast cancer — in vivo / RNAi studyView study →Reference 2Krall AS et al. · 2021AnimalAsparagine couples mitochondrial respiration to ATF4 activity and tumor growth — in vivo / mechanisticView study →}, and dietary asparagine restriction is under study as an adjunct. Deliberately loading asparagine is therefore, if anything, a reason for caution in people with cancer rather than a benefit.

Scope disclosure. Interactions were assessed: the material one is asparaginase. Pregnancy and lactation were assessed only partially — no supplement-specific data exist; dietary intake is not a concern, and concentrated supplementation is unstudied. No Upper Limit has been set, which does not imply that unlimited intake is safe — standalone high doses are simply uncharacterised. Where something was not studied, it is marked “not assessed,” not “safe.”

Pregnancy & Lactation

Not established in pregnancy Not established in lactation

No standalone-supplement safety data; ordinary dietary intake is not a concern. Asparagine obtained from food as part of normal dietary protein raises no issue in pregnancy or lactation. Isolated, concentrated supplementation has not been studied in these populations and cannot be assumed safe.

References

Knott SRV, Wagenblast E, Khan S, et al. (2018). Asparagine bioavailability governs metastasis in a model of breast cancer — in vivo / RNAi study. Nature. https://pubmed.ncbi.nlm.nih.gov/29414946/
Krall AS, Mullen PJ, Surjono F, et al. (2021). Asparagine couples mitochondrial respiration to ATF4 activity and tumor growth — in vivo / mechanistic. Cell Metabolism. https://pubmed.ncbi.nlm.nih.gov/33609439/
Jiang J, Batra S, Zhang J (2021). Asparagine: a metabolite to be targeted in cancers — review. Metabolites. https://pubmed.ncbi.nlm.nih.gov/34205460/
Chiu M, Taurino G, Bianchi MG, et al. (2019). Asparagine synthetase in cancer: beyond acute lymphoblastic leukemia — review. Frontiers in Oncology. https://pubmed.ncbi.nlm.nih.gov/31998641/
Chen SH (2015). Asparaginase therapy in pediatric acute lymphoblastic leukemia: a focus on the mode of drug resistance — review. Pediatrics and Neonatology. https://pubmed.ncbi.nlm.nih.gov/25603726/
Lomelino CL, Andring JT, McKenna R, Kilberg MS (2017). Asparagine synthetase: function, structure, and role in disease — review. Journal of Biological Chemistry. https://pubmed.ncbi.nlm.nih.gov/29084849/
Cooper AJL, Shurubor YI, Dorai T, et al. (2016). ω-Amidase: an underappreciated but important enzyme in L-glutamine and L-asparagine metabolism — review. Amino Acids. https://pubmed.ncbi.nlm.nih.gov/26259930/
Yazicioglu YF, Marin E, Andrew HF, et al. (2024). Asparagine availability controls germinal center B cell homeostasis — in vivo / mechanistic. Science Immunology. https://pubmed.ncbi.nlm.nih.gov/39671468/
Yaylayan VA, Stadler RH (2005). Acrylamide formation in food: a mechanistic perspective — mechanistic review. Journal of AOAC International. https://pubmed.ncbi.nlm.nih.gov/15759750/
Oliver SL, Yobi A, Flint-Garcia S, Angelovici R (2024). Reducing acrylamide formation potential by targeting free asparagine accumulation in seeds — review/perspective. Journal of Agricultural and Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/38483189/
Parisi A, Quaranta F, Masala D, et al. (2007). Do aspartate and asparagine acute supplementation influence the onset of fatigue in intense exercise? — randomised double-blind pilot. Journal of Sports Medicine and Physical Fitness. https://pubmed.ncbi.nlm.nih.gov/18091682/
Brewer GJ, Torricelli JR, Evege EK, Price PJ (1993). Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination — in vitro. Journal of Neuroscience Research. https://pubmed.ncbi.nlm.nih.gov/8377226/
Richards NGJ, Kilberg MS (2006). Asparagine synthetase chemotherapy — review. Annual Review of Biochemistry. https://pubmed.ncbi.nlm.nih.gov/16756505/